AmerisourceBergen throws down nearly $1.3B cash for German life sciences company
AmerisourceBergen earned a whopping $60.1 billion last quarter, thanks in part to its distribution of government-owned Covid treatments. Now it’s time to reinvest some of that cash.
The pharmaceutical distributor is plunking down $1.28 billion to acquire PharmaLex, a German life sciences company that boasts a range of consulting and support services from clinical development to post-launch, the companies announced on Monday.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.